Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TP vs TAC in Neoadjuvant TNBC (HELEN-001)
NCT04664972Phase 2Completed
- Sponsor
- Henan Cancer Hospital
- Start
- Nov 2018
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin in triple-negative breast cancer (TNBC), sponsored by Henan Cancer Hospital. Started Nov 2018; status: completed.
02
Drugs
cisplatin
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT04664972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04664972.